KA MacLennan

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

KM Ardeshna, Peter Smith, AJ Norton et al. · The Lancet · 2003 · 538 citations

Lymphoid Neoplasia, Long-term Effect, Health Policy +4

Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification Project

Thomas Rüdiger, Dennis D. Weisenburger, J R Anderson et al. · Annals of Oncology · 2002 · 418 citations · Full text

Induction of transforming growth factor beta 1 in human breast cancer in vivo following tamoxifen treatment.

A Butta, KA MacLennan, K C Flanders et al. · PubMed · 1992 · 343 citations

Breast Oncology, Tamoxifen Treatment, Human Growth +17

Prognostic significance of BCL-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin's lymphoma: a British National Lymphoma Investigation Study

ME Hill, KA MacLennan, David Cunningham et al. · Blood · 1996 · 311 citations · Full text

Enhanced large intestinal potassium permeability in end‐stage renal disease

Thiriloganathan Mathialahan, KA MacLennan, L N Sandle et al. · The Journal of Pathology · 2005 · 140 citations